Animal models used in the research of nanoparticles for cardiovascular diseases
Cardiovascular disease (CVD) is the leading cause of mortality and morbidity worldwide. Tremendous progress has been made in the prevention and treatment of CVD, however there are still lots of limitations and new technology is needed. Nanoparticles has been studies recently for CVD due to their nan...
Main Authors: | Shang, Lijun, Dong, Caijuan, Ma, Aiqun |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer
2021
|
Subjects: | |
Online Access: | https://repository.londonmet.ac.uk/6916/7/Revision-SHANG-v1.pdf |
Similar Items
-
GLP-2 decreases food intake in the dorsomedial hypothalamic nucleus (DMH) through Exendin (9-39) in male Sprague-Dawley (SD) rats
by: Sun, Huiling, et al.
Published: (2021) -
A pilot study on peptidylarginine deiminases and protein deimination in animal cancers across vertebrate species
by: Inal, Jameel, et al.
Published: (2022) -
Exploring the potential of the recombinant human collagens for biomedical and clinical: a short review
by: Chen, Zhuoyue, et al.
Published: (2021) -
An investigation of rhinovirus infection on cellular uptake of poly (glycerol-adipate) nanoparticles
by: Abo-zeid, Yasmin, et al.
Published: (2020) -
Efficacy of docosahexaenoic acid-enriched formula to enhance maternal and fetal blood docosahexaenoic acid levels: randomized double-blinded placebo-controlled trial of pregnant women with gestational diabetes mellitus
by: Min, Yoeju, et al.
Published: (2015)